These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4595363)

  • 1. [New aspects of the treatment of diabetic retinopathy].
    Regnault F; Barre Y; Rietzler X; Foucquier E; Aubert P; Molinier A; Zara M
    Therapeutique; 1973; 49(7):505-7. PubMed ID: 4595363
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of gliclazide on platelet behavior].
    Verry M; Dechavanne M; Desnoyers P; Stoltz JF; Vainer H
    Nouv Presse Med; 1974 Oct; 3(33):2099-100. PubMed ID: 4471584
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
    Simonin R
    Mars Med; 1972; 109(10):655-8. PubMed ID: 4659845
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gliclazide, a new antidiabetic with hemobiologic and vascular properties].
    Plauchu M; Pousset G
    Lyon Med; 1972 Oct; 228(16):383-5. PubMed ID: 4637685
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long term study of a new antidiabetic agent in 1183 cases].
    Riveline B
    Sem Hop Ther; 1974 Feb; 50(2):133-9. PubMed ID: 4612707
    [No Abstract]   [Full Text] [Related]  

  • 6. The pharmacology of S 1702, a new highly effective oral antidiabetic drug with unusual properties. 2. Protective activity of S 1702 on the microvascular system in normal and diabetic rats.
    Duhault J; Lebon F
    Arzneimittelforschung; 1972 Oct; 22(10):1686-90. PubMed ID: 4677057
    [No Abstract]   [Full Text] [Related]  

  • 7. [The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)].
    Masbernard A; Portal A
    Therapeutique; 1972 Nov; 48(9):569-73. PubMed ID: 4650526
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diamicron].
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):343-9. PubMed ID: 4679568
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new antidiabetic agent: glyclazide. A study of glycemic regulation].
    Bour H; Denard Y; Plauchu M; Rathery M; Simonin R; Thervet F; Warembourg H
    Nouv Presse Med; 1974 Feb; 3(5):249-51. PubMed ID: 4819946
    [No Abstract]   [Full Text] [Related]  

  • 10. [Platelet adhesiveness and diamicron in human clinical practice].
    Daver J; Izarn P; Menache D; Paleirac G; Streiff F
    Therapeutique; 1973 Apr; 49(4):279-82. PubMed ID: 4775222
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trial of glypizide].
    Cañadell Vidal J
    Rev Iber Endocrinol; 1974 Jan; 21(121):61-73. PubMed ID: 4826383
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diabetic retinopathy. Effects of gliclazide].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1983; ():275-80. PubMed ID: 6358618
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug therapy regimens in diabetic retinopathy].
    Mitulescu D; Selaru D; Ocian R
    Oftalmologia; 1999; 46(1):63-6. PubMed ID: 10641089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.
    Desnoyers P; Labaume J; Anstett M; Herrera M; Pesquet J; Sebastien J
    Arzneimittelforschung; 1972 Oct; 22(10):1691-5. PubMed ID: 4677058
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study with glypentide, new sulfonylurea hypoglycemic agent].
    Pou Torelló JM; Vilaclara JM
    Rev Iber Endocrinol; 1974; 21(125):427-30, 433-8, 441-2 passim. PubMed ID: 4608666
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of a new sulfonylurea antidiabetic, glibornuride].
    Vernet A; Fabre J; Zahnd G
    Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1599-607. PubMed ID: 4630563
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with the oral antidiabetic agent, Glurenorm, in diabetics with kidney diseases].
    Uglesic A; Ljahnicky N
    Med Monatsschr; 1975 Sep; 29(9):408-11. PubMed ID: 1102900
    [No Abstract]   [Full Text] [Related]  

  • 18. Improvement in motor nerve conduction following treatment in newly diagnosed diabetics.
    Ward JD
    Adv Metab Disord; 1973; 2():Suppl 2:569-73. PubMed ID: 4720388
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the fructose therapy of diabetic retinopathy].
    Schrader KE; Mähr G; Neumann P
    Dtsch Med Wochenschr; 1966 Feb; 91(7):306-8. PubMed ID: 5323805
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of platelets in pathogenesis of diabetic retinopathy.
    Dobbie JG; Kwaan HC; Colwell JA; Suwanwela N
    Trans Am Acad Ophthalmol Otolaryngol; 1973; 77(1):OP43-7. PubMed ID: 4730082
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.